X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. Aphidicolin, (3-s-(3alpha,4beta,4abeta,6aalpha,8alpha,9alpha,11aalpha,11balpha))-isomer
2. Ici 69653
3. Ici-69653
4. Ici69653
5. Nsc 234714
6. Nsc 351140
7. Nsc-234714
8. Nsc-351140
9. Nsc234714
10. Nsc351140
1. 38966-21-1
2. (+)-aphidicolin
3. (+/-)-aphidicolin
4. Ici 69653
5. Nsc-234714
6. Aphidicolin, (+/-)-
7. (3r,4r,4ar,6as,8r,9r,11as,11bs)-4,9-bis(hydroxymethyl)-4,11b-dimethyltetradecahydro-8,11a-methanocyclohepta[a]naphthalene-3,9-diol
8. Nsc234714
9. 6b3f8qw8tu
10. Chembl29711
11. Mls000069677
12. Chebi:2766
13. 69926-98-3
14. 192tj6pp19
15. 9,15-cyclo-c,18-dinor-14,15-secoandrostane-4,17-dimethanol, 3,17-dihydroxy-4-methyl-, (3alpha,4alpha,5alpha,17alpha)-
16. Smr000058538
17. 8,11
18. A-methano-11ah-cyclohepta[a]naphthalene-4,9-dimethanol,tetradecahydro-3,9-dihydroxy-4,11b-dimethyl-, (3r,4r,4ar,6as,8r,9r,11as,11bs)-
19. 8,11a-methano-11ah-cyclohepta(a)naphthalene-4,9-dimethanol, Tetradecahydro-3,9-dihydroxy-4,11b-dimethyl-, (3r,4r,4ar,6as,8r,9r,11as,11bs)-rel-
20. Rel-(3r,4r,4ar,6as,8r,9r,11as,11bs)-4,9-bis(hydroxymethyl)-4,11b-dimethyltetradecahydro-8,11a-methanocyclohepta[a]naphthalene-3,9-diol
21. Nsc 234714
22. Ccris 1783
23. Ici-69653
24. Mfcd00083214
25. Unii-6b3f8qw8tu
26. Aphidicholin
27. Aphidocolin
28. Brn 4689958
29. Unii-192tj6pp19
30. Bis(hydroxymethyl)-dimethyl-[?]diol
31. Aphidicolin From Nigrospora Sphaerica
32. Ne-3,9-diol
33. Aphidicolin [mi]
34. Opera_id_1321
35. Cbiol_001873
36. Bspbio_001438
37. Kbiogr_000158
38. Kbioss_000158
39. Schembl183956
40. Cid_457964
41. Megxm0_000277
42. Aphidicolin, Analytical Standard
43. Dtxsid5036711
44. Acon0_000080
45. Acon1_000511
46. Bcbcmap01_000163
47. Kbio2_000158
48. Kbio2_002726
49. Kbio2_005294
50. Kbio3_000315
51. Kbio3_000316
52. Bio1_000159
53. Bio1_000648
54. Bio1_001137
55. Bio2_000158
56. Bio2_000638
57. Hms1361h20
58. Hms1791h20
59. Hms1989h20
60. Hms3402h20
61. Hy-n6733
62. Zinc3789195
63. Bdbm50090910
64. Akos027470273
65. Aphidicolin - Cas 38966-21-1
66. At25347
67. Ccg-208640
68. Idi1_033908
69. Smp1_000025
70. Ncgc00023142-03
71. Ncgc00023142-04
72. Ncgc00023142-05
73. Ncgc00023142-06
74. 8,11a-methano-11ah-cyclohepta(a)naphthalene-4,9-dimethanol, Tetradecahydro-3,9-dihydroxy-4,11b-dimethyl-, (3r-(3-alpha,4-alpha,4a-alpha,6a-beta,8-beta,9-beta,11a-beta,11b-beta))-
75. Ba162709
76. 3alpha,16,17,18-tetrahydroxyaphidicolone
77. Cs-0033151
78. 966a211
79. Q27453425
80. 4b15b386-8738-48fe-80db-5ba3406098dd
81. Aphidicolin From Nigrospora Sphaerica, >=98% (hplc), Powder
82. (1s,2s,5r,6r,7r,10s,12r,13r)-6,13-bis(hydroxymethyl)-2,6-dimethyltetracyclo[10.3.1.0[1,10].0[2,7]]hexadecane-5,13-diol
83. (3alpha,4alpha,5alpha,17alpha)-3,17-dihydroxy-4-methyl-9,15-cyclo-c,18-dinor-14,15-secoandrostane-4,17-dimethanol
84. (3r,4r,4ar,6as,8r,9r,11as,11bs)-4,9-bis(hydroxymethyl)-4,11b-dimethyltetradecahydro-8,11a-methanocyclohepta[a]naphthale
85. (3r,4r,4ar,6as,8r,9r,11as,11bs)-tetradecahydro-3,9-dihydroxy-4,11b-dimethyl-8,11a-methano-11ah-cyclohepta[a]naphthalene-4,9-dimethanol
86. 2ze
87. 6,13-di(hydroxymethyl)-2,6-dimethyl-(1s,2s,5r,6r,7r)-tetracyclo[10.3.1.01,10.02,7]hexadecane-5,13-diol
88. 6,13-di(hydroxymethyl)-2,6-dimethyl-(1s,2s,5r,6r,7r,10s,12r,13r)-tetracyclo[10.3.1.01,10.02,7]hexadecane-5,13-diol (aphidicolin)
89. 6,13-di(hydroxymethyl)-2,6-dimethyl-(1s,2s,5r,6r,7r,10s,12r,13r)-tetracyclo[10.3.1.01,10.02,7]hexadecane-5,13-diol(aphidicolin)
90. 8,11a-methano-11ah-cyclohepta(a)naphthalene-4,9-dimethanol, Tetradecahydro-3,9-dihydroxy-4,11b-dimethyl-, (3r,4r,4ar,6as,8r,9r,11as,11bs)-
91. 8,11a-methano-11ah-cyclohepta[a]naphthalene-4,9-dimethanol, Tetradecahydro-3,9-dihydroxy-4,11b-dimethyl-, (3s,4r,4ar,6as,8r,9r,11as,11bs)-
92. 9,15-cyclo-c,18-dinor-14,15-secoandrostane-4,17-dimethanol, 3,17-dihydroxy-4-methyl-, (3.alpha.,4.alpha.,5.alpha.,17.alpha.)-
| Molecular Weight | 338.5 g/mol |
|---|---|
| Molecular Formula | C20H34O4 |
| XLogP3 | 2.5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 338.24570956 g/mol |
| Monoisotopic Mass | 338.24570956 g/mol |
| Topological Polar Surface Area | 80.9 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 524 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antiviral Agents
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Market Place
